| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $424.6M | — | -5.9% |
| Cost of Revenue | $174.3M | — | -6.8% |
| Gross Profit | $222.7M | — | -6.0% |
| R&D Expense | $69.7M | — | +14.7% |
| SG&A Expense | $45.2M | — | +15.3% |
| Operating Income | $10.4M | — | -78.4% |
| Pre-tax Income | $12.3M | — | -75.7% |
| Income Tax | $3.7M | — | -64.7% |
| Net Income | $7.8M | — | -79.4% |
| EPS (Basic) | $0.16 | — | -77.1% |
| EPS (Diluted) | $0.15 | — | -77.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $320.0M | -6.4% | +11.9% |
| Short-term Investments | $28.3M | +22.0% | +3.8% |
| Accounts Receivable | $448.3M | -23.0% | -30.7% |
| Current Assets | $940.3M | -12.3% | -13.3% |
| Total Assets | $2.07B | -5.9% | -2.6% |
| Current Liabilities | $737.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $48.2M | — | -22.7% |
| Investing Cash Flow | -$37.9M | — | -116.2% |
| Financing Cash Flow | -$31.3M | — | +42.9% |
| -16.9% |
| Total Liabilities | $902.6M | -11.1% | -12.2% |
| Stockholders' Equity | $1.13B | -1.4% | +6.4% |